D.E. Shaw & Co
INSY

D.E. Shaw & Co’s Insys Therapeutics, Inc. INSY Stock Holding History

D.E. Shaw & Co’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-324,957
Closed -$1.5M – 4009
2019
Q1 		$1.5M Sell
324,957
-187,487
-37% -$888K ﹤0.01% 2350
2018
Q4 		$1.79M Buy
512,444
+314,264
+159% +$2.18M ﹤0.01% 2245
2018
Q3 		$2M Buy
198,180
+150,935
+319% +$1.2M ﹤0.01% 2201
2018
Q2 		$342K Buy
+47,245
New +$329K ﹤0.01% 3312
2018
Q1 		– Sell
-125,905
Closed -$1.21M – 3914
2017
Q4 		$1.21M Sell
125,905
-8,809
-7% -$57.6K ﹤0.01% 2470
2017
Q3 		$1.2M Buy
134,714
+4,189
+3% +$43.2K ﹤0.01% 2386
2017
Q2 		$1.65M Buy
130,525
+115,169
+750% +$1.36M ﹤0.01% 2102
2017
Q1 		$161K Buy
+15,356
New +$164K ﹤0.01% 3154
2016
Q4 		– Sell
-50,147
Closed -$591K – 3698
2016
Q3 		$591K Sell
50,147
-119,930
-71% -$1.82M ﹤0.01% 2705
2016
Q2 		$2.2M Buy
170,077
+66,636
+64% +$971K ﹤0.01% 1870
2016
Q1 		$1.65M Buy
+103,441
New +$1.96M ﹤0.01% 2008
2015
Q3 		– Sell
-63,642
Closed -$2.29M – 4014
2015
Q2 		$2.29M Buy
+63,642
New +$1.98M ﹤0.01% 2084
2014
Q2 		– Sell
-305,628
Closed -$4.94M – 4682
2014
Q1 		$6.33M Buy
305,628
+172,428
+129% +$3.42M 0.01% 1390
2013
Q4 		$1.72M Sell
133,200
-33,285
-20% -$462K ﹤0.01% 2664
2013
Q3 		$1.94M Buy
+166,485
New +$1.37M ﹤0.01% 2458

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

D.E. Shaw & Co's INSY Position: Q2 2019 in Review

D.E. Shaw & Co sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 324,957 shares — an estimated $1.5M sold.

D.E. Shaw & Co first reported a position in INSY in Q3 2013 and held it in 15 quarters. The position peaked at $6.33M in Q1 2014. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • D.E. Shaw & Co reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 324,957 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $1.5M.
  • D.E. Shaw & Co first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 15 quarters.
  • D.E. Shaw & Co's Insys Therapeutics, Inc. position peaked at $6.33M in Q1 2014.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.